Nothing but negotiation

The Gap Partnership

Nabi stockholders receive letter from Mangrove Partners

Mangrove Partners has called on fellow Nabi stockholders to reject a possible merger.

20 August 2012

Negotiation strategies are in full flow at Nabi Biopharmaceuticals, as one of its largest stockholders has urged others with shares in the company to reject a merger.

The Mangroves Partners Fund delivered a letter to Nabi stockholders in an effort to get them to turn down a takeover deal with Melbourne-based Biota Holdings.

In the letter, Mangrove stated the transaction would result in loss of value, with the company estimating stocks to be worth around $2.40 (£1.53) per share.

Other concerns listed by the firm included Biota's lack of financial strength - with the organisation operating at a loss for the last two years - and an uncertain management structure.

Mangrove, which provides investment advice on specialised hedge funds, claimed the merger was being completed in order to give Nabi executives more lucrative bonuses and leadership positions.

"It seems clear to us that the proposed transaction has no merit and destroys value for both Nabi and Biota stockholders," the letter explained.

Posted by Edel Quinn

Source: Mangrove press release, August 16th

Gap News

March 2014

The Negotiation Roadshow 2014

Generating value through creative negotiation

Read more

July 2013

Trading Global: Negotiating in the Far East

The Gap Partnership are hosting a complimentary Lunch & Learn seminar in association with UK Trade & Investment

Read more

April 2013

GroceryAid Negotiation Event Raises £26,550

The Gap Partnership, in conjunction with Asda, SC Johnson and Waitrose, host one-day negotiation workshop

Read more

February 2013

Trading Global - Negotiating in the Far East

What is the impact of cultural differences on your negotiations?

Read more

December 2012

The Gap Partnership Release New Negotiation Video

The Nothing but Negotiation video series continues with collaborative negotiation

Read more